A year after launching the test in the US, the company is making it available in more than 100 countries, partnering with distributors in Israel, Turkey, and Finland.
Under the terms of the deal, Color Genomics will integrate Kapa Biosystems' library construction reagents into its NGS workflow.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
Diatherix and Color Genomics now carry both CLIA certification and CAP accreditation.
Researchers are hoping the 100,000-patient WISDOM study will lead to genetically informed breast cancer screening based on a woman's unique risk factors.
Color Genomics hopes its recently launched benefits program will enable a broader population to have access to breast and ovarian cancer risk testing.
The company offers a panel that analyzes 19 genes associated with breast and ovarian cancer, including BRCA1/2, for $249.
A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.
South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.
In Science this week: the synthetic genetic system hachimoji, and more.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.